Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Author Correction: Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases (npj Parkinson's Disease, (2023), 9, 1, (161), 10.1038/s41531-023-00604-y)

Altay MF. et al, (2024), npj Parkinson's Disease, 10

Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases.

Altay MF. et al, (2023), NPJ Parkinsons Dis, 9

Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders.

Altay MF. et al, (2022), Acta Neuropathol Commun, 10

Differential microRNA expression analyses across two brain regions in Alzheimer's disease.

Dobricic V. et al, (2022), Transl Psychiatry, 12

Neuropathological evidence of body-first vs. brain-first Lewy body disease

Borghammer P. et al, (2022), Neurobiology of Disease

Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies.

Poggiolini I. et al, (2021), Brain

Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture.

Chia R. et al, (2021), Nat Genet, 53, 294 - 303

Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study.

Attems J. et al, (2021), Acta Neuropathol, 141, 159 - 172

Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies.

Orme T. et al, (2020), Acta Neuropathol Commun, 8

Alzheimer's disease pathology explains association between dementia with Lewy bodies and APOE‐ε4/TOMM40 long poly‐T repeat allele variants

Prokopenko I. et al, (2019), Alzheimer's and Dementia: Translational Research and Clinical Interventions, 5, 814 - 824

Heritability and genetic variance of dementia with Lewy bodies.

Guerreiro R. et al, (2019), Neurobiol Dis, 127, 492 - 501

A comprehensive screening of copy number variability in dementia with Lewy bodies.

Kun-Rodrigues C. et al, (2019), Neurobiol Aging, 75, 223.e1 - 223.e10

Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease.

Ruffmann C. et al, (2018), Neuropathol Appl Neurobiol, 44, 722 - 736

LRP10 in α-synucleinopathies

Guerreiro R. et al, (2018), The Lancet Neurology, 17, 1032 - 1033

Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study.

Guerreiro R. et al, (2018), Lancet Neurol, 17, 64 - 74

DNAJC12 and dopa-responsive nonprogressive parkinsonism

Straniero L. et al, (2017), Annals of Neurology, 82, 640 - 646

MAPT Genetic Variation and Neuronal Maturity Alter Isoform Expression Affecting Axonal Transport in iPSC-Derived Dopamine Neurons.

Beevers JE. et al, (2017), Stem Cell Reports, 9, 587 - 599

Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies.

Kun-Rodrigues C. et al, (2017), Neurobiol Aging, 49, 214.e13 - 214.e15

DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study

Parkkinen LJ., (2016), Lancet Neurology

Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies.

Fairfoul G. et al, (2016), Ann Clin Transl Neurol, 3, 812 - 818

Load More

Include forthcoming?